Cyclophosphamide,Doxorubicin,Vincristine,Prednisone
not tagged
['ptcl', 'lymsm']
umbrella design in ptcl! chop+x. compared to chop only cohort, non randomised. 1 yr pfs 63 vs 33%. difficult to understand benefit given design but great to see feasibility of such an approach #lymsm #icml23 
Haematologist with clinical and academic interest in T-cell lymphoma. University Hospitals of Leicester.